Literature DB >> 25630030

Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain.

Jane C Ballantyne1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25630030     DOI： 10.1097/j.pain.0000000000000105

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  12 in total

1.  CBT to reduce healthcare use for medically unexplained symptoms: systematic review and meta-analysis.

Authors:  Brittni Jones; Amanda C de C Williams
Journal:  Br J Gen Pract       Date:  2019-01-28       Impact factor: 5.386

2.  The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary.

Authors:  Ajay Manhapra; Albert J Arias; Jane C Ballantyne
Journal:  Subst Abus       Date:  2017-10-18       Impact factor: 3.716

3.  SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain.

Authors:  John Markman; Jeffrey Gudin; Richard Rauck; Charles Argoff; Michael Rowbotham; Eva Agaiby; Joseph Gimbel; Nathaniel Katz; Stephen K Doberstein; Mary Tagliaferri; Lin Lu; Suresh Siddhanti; Martin Hale
Journal:  Pain       Date:  2019-06       Impact factor: 7.926

4.  Examining patterns in opioid prescribing for non-cancer-related pain in Wales: preliminary data from a retrospective cross-sectional study using large datasets.

Authors:  Emma Davies; Ceri Phillips; Jaynie Rance; Berni Sewell
Journal:  Br J Pain       Date:  2018-09-25

5.  Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (Opioids-Markers-Arthroprosthesis) study protocol for a randomized controlled trial.

Authors:  Valentina Malafoglia; Monica Celi; Carolina Muscoli; Sara Ilari; Filomena Lauro; Luigino Antonio Giancotti; Chiara Morabito; Maurizio Feola; Umberto Tarantino; William Raffaeli
Journal:  Trials       Date:  2017-12-19       Impact factor: 2.279

Review 6.  Chronic pain and opioid misuse: a review of reviews.

Authors:  Pauline Voon; Mohammad Karamouzian; Thomas Kerr
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-08-15

7.  [Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse].

Authors:  W Häuser; T Schubert; N Scherbaum; T Tölle
Journal:  Schmerz       Date:  2018-12       Impact factor: 1.107

8.  Stopping or Decreasing Opioid Therapy in Patients on Chronic Opioid Therapy.

Authors:  Joseph V Pergolizzi; Giustino Varrassi; Antonella Paladini; JoAnn LeQuang
Journal:  Pain Ther       Date:  2019-08-03

9.  Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain.

Authors:  Jack E Henningfield; Jeffrey Gudin; Richard Rauck; Joseph Gimbel; Mary Tagliaferri; Stephen K Doberstein; Carlo Di Fonzo; Lin Lu; Nathaniel Katz; Suresh Siddhanti; Sidney Schnoll
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

10.  Trends in risky prescriptions of opioid analgesics from 2011 to 2015 in Northern Germany.

Authors:  Uwe Verthein; Sven Buth; Anne Daubmann; Marcus-Sebastien Martens; Bernd Schulte
Journal:  J Psychopharmacol       Date:  2020-07-17       Impact factor: 4.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.